C. Sauvage

Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.

A. Muraro, M. Fernández-Rivas, K. Beyer, 2020, The Lancet. Child & adolescent health.

Intestinal permeability and fecal eosinophil-derived neurotoxin are the best diagnosis tools for digestive non-IgE-mediated cow’s milk allergy in toddlers

N. Kapel, C. Dupont, M. Butel, 2012, Clinical chemistry and laboratory medicine.

Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.

V. Leblond, C. Cordonnier, R. Herbrecht, 1995, Journal of chemotherapy.

Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group.

D. Blaise, X. Troussard, G. Marit, 1995, Blood.

Phenotypical characterization of peanut allergic children with differences in cross‐allergy to tree nuts and other legumes

M. Cousin, A. Lansiaux, A. Vilain, 2017, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

A Novel Immunoassay Using Recombinant Allergens Simplifies Peanut Allergy Diagnosis

P. Vallois, D. Moneret-vautrin, M. Morisset, 2010, International Archives of Allergy and Immunology.

Epicutaneous Immunotherapy (EPIT) Is Effective and Safe to Treat Peanut Allergy: A Multi-National Double-Blind Placebo-Controlled Randomized Phase IIb Trial

William H. Yang, M. Kowalski, R. V. Wijk, 2015 .